Future Directions of Pharmacovigilance Studies Using Electronic Medical Recording and Human Genetic Databases-Reference-Cited by-同舟云学术

Future Directions of Pharmacovigilance Studies Using Electronic Medical Recording and Human Genetic Databases

Published:2019-10-15 Issue:4 Volume:35 Page:319-330
ISSN:1976-8257
Container-title:Toxicological Research
language:en
Short-container-title:ToxicolRes

Author:

Choi Young Hee¹,Han Chang Yeob²,Kim Kwi Suk³,Kim Sang Geon³⁴

Affiliation:

1. College of Pharmacy, Dongguk University_Seoul, Goyang, Korea

2. Department of Pharmacology, School of Medicine, Wonkwang University, Iksan, Korea

3. Department of Pharmacy, Seoul National University Hospital, Seoul, Korea

4. College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea

Funder

Seoul National University Hospital

Publisher

The Korean Society of Toxicology

Subject

Health, Toxicology and Mutagenesis,Toxicology

Link

http://pdf.medrang.co.kr/TR/2019/035/TR035-04-04.pdf

Reference83 articles.

1. Liu, M, Melton, BL, Ator, G, and Waitman, LR (2017). Integrating medication alert data into a clinical data repository to enable retrospective study of drug interaction alerts in clinical practice. AMIA Jt Summits Transl Sci Proc. 2017, 213-220.

2. Effects of clinical decision-support systems on practitioner performance and patient outcomes: a synthesis of high-quality systematic review findings

3. The Inevitable Application of Big Data to Health Care

4. ClinicalCodes: An Online Clinical Codes Repository to Improve the Validity and Reproducibility of Research Using Electronic Medical Records

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-Related Glomerular Phenotypes: A Global Pharmacovigilance Perspective;Journal of Clinical Medicine;2024-08-18

2. A 10‐year retrospective study of antibacterial‐induced thrombocytopenia in a women and children hospital using China Hospital Pharmacovigilance System and Visual Basic for Applications;British Journal of Clinical Pharmacology;2024-04-10

3. Pharmacovigilance Through Phased Clinical Trials, Post-Marketing Surveillance and Ongoing Life Cycle Safety;The Quintessence of Basic and Clinical Research and Scientific Publishing;2023

4. Analyzing adverse drug reaction using statistical and machine learning methods;Medicine;2022-06-24

5. Artificial Intelligence-Based Pharmacovigilance in the Setting of Limited Resources;Drug Safety;2022-05